Results 201 to 210 of about 159,323 (346)

Correction to: Total-body ¹¹C-PIB PET/CT imaging of systemic amyloidosis: interorgan connectivity in cardiac amyloidosis for prognostic insights. [PDF]

Eur J Nucl Med Mol Imaging
Hong Z, Xue S, Yu J, Calabretta R, Haberl D, Jiang Z, Grünert S, Beitzke D, Kammerlander A, Hacker M, Li X.   +10 more
europepmc   +1 more source

Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis [PDF]

, 2019
Lenihan, Daniel J, Stockerl-Goldstein, Keith E, Zhang, Kathleen W   +2 more
core   +1 more source

Rate of MGUS Progression to Haematological Malignancies: A Systematic Review

European Journal of Haematology, Volume 116, Issue 6, Page 889-906, June 2026.
ABSTRACT Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic pre‐cancerous condition that precedes plasma cell dyscrasias, including multiple myeloma (MM). Current clinical guidelines report that MGUS's rate of malignant progression to haematological malignancy (HM) is ~1% per year; however, reported rates have varied widely ...
Stephen James Quinn, Chris Cardwell, Lesley Ann Anderson, Charlene McShane   +3 more
wiley   +1 more source

Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant

Kidney International Reports, 2017
Tatiana Prokaeva, Harun Akar, Brian Spencer, Andrea Havasi, Haili Cui, Carl J. O’Hara, Olga Gursky, John Leszyk, Martin Steffen, Sabrina Browning, Allison Rosenberg, Lawreen H. Connors   +11 more
doaj   +1 more source

Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change

Alzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract INTRODUCTION Alzheimer's disease neuropathologic change (ADNC) classification identifies not/low and intermediate/high levels of neuropathology. Our goal was to assess how frequently a positive amyloid positron emission tomography (PET) scan indicates not/low ADNC and whether this autopsy finding can occur >10 years after a positive amyloid ...
Brian J. Burkett, Heather J. Wiste, Derek R. Johnson, Bradley F. Boeve, Kejal Kantarci, Ronald C. Petersen, David S. Knopman, Prashanthi Vemuri, Jonathan Graff‐Radford, Val Lowe, Petrice M. Cogswell, Jay Pillai, Christopher G. Schwarz, Aivi T. Nguyen, Melissa E. Murray, Dennis W. Dickson, Clifford R. Jack Jr   +16 more
wiley   +1 more source

Rare case of young cardiac amyloidosis: difficult diagnostic pathway in routine clinical care. [PDF]

Eur Heart J Case Rep
Chumakova OS, Dankovtseva EN, Sannikova MA, Mershina EA, Alexandrova SA, Stepanova EA, Suvorina MY, Zateyshchikov DA.   +7 more
europepmc   +1 more source

Long-term AL primary amyloidosis. A case report.

, 1995
Vera A. Chotzen, Regina Gandour‐Edwards, Michael K Zang, Phil Vogt   +3 more
openalex   +2 more sources

BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer’s disease [PDF]

, 2013
Rebecca M. Burke, Timothy A. Norman, Tarik F. Haydar, Barbara E. Slack, Susan E. Leeman, Jan Krzysztof Blusztajn, Tiffany J. Mellott   +6 more
openalex   +1 more source

Abi3S212F Alzheimer's disease variant alters plaque structure and disrupts microglia

Alzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract BACKGROUND Genetic variants affecting microglial function can influence Alzheimer's disease (AD) risk, yet the underlying mechanisms remain unclear. The AD‐associated ABI3S209F (Abi3S212F in mouse) variant regulates cytoskeletal dynamics, but its in vivo impact on pathology is unknown. METHODS: An Abi3S212F mouse was developed and crossed with
Claire A. Butler, Min Sung Gee, Katie O'Gara, Giedre Milinkeviciute, Celia Da Cunha, Shimako Kawauchi, Yueh‐Hao Lu, Nellie Kwang, Kate I. Tsourmas, Christiana Prekopa, Zechuan Shi, Heidi Yahan Liang, Sherilyn D. Collins, Zachary A. Pashkutz, Jenna A. Sanchez, Kai‐Xuan Shi, Amber D. Walker, Shuling Wang, Maigan L. A. Wong, Karina Genaro, Jonathan Neumann, Angela Gomez‐Arboledas, Duc M. Duong, Nicholas T. Seyfried, Andrea J. Tenner, Frank M. LaFerla, Ali Mortazavi, Vivek Swarup, Grant R. MacGregor, Kim N. Green   +29 more
wiley   +1 more source

Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. [PDF]

World J Exp Med
Bouziane M, Moufid O, Habbal R.
europepmc   +1 more source